(Q70118170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

D Palm

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

293-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00544083

8 October 2019

exact match

0 references

cites work

Likely explanation for longer duration of pharmacological (antianginal) effects of propranolol in relation to its short half-life

1 reference

12 December 2020

Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers

1 reference

12 December 2020

Single and divided doses of penbutolol

1 reference

12 December 2020

Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma

1 reference

12 December 2020

On the pharmacology of the beta-receptor blocker penbutolol (author's transl)

1 reference

12 December 2020

Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte

1 reference

12 December 2020

Plasma Level Studies of Penbutolol After Oral Dose in Man

1 reference

12 December 2020

Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man

1 reference

12 December 2020

Penbutolol Pharmacokinetics: the influence of concomitant administration of cimetidine

1 reference

12 December 2020

Physico-chemical and anlytical studies of penbutolol

1 reference

12 December 2020

Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat

1 reference

12 December 2020

Kinetics of pharmacologic response

1 reference

12 December 2020

The beta-adrenergic receptor-adenyl-cyclase system of rat reticulocytes: effects of adrenergic stimulants and inhibitors

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic study of oral and intravenous penbutolol

1 reference

12 December 2020

Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Plasma Level Profiles and Clinical Response of Penbutolol After Three Different Single Oral Doses in Man

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00544083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3000796%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference